Lysophospholipid regulates release and activation of latent TGF-β1 from chondrocyte extracellular matrix

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1684, Issue 1-3, 2004, Pages 18-28

  Gay, I ^a   Schwartz, Z ^a,b,c   Sylvia, V L ^a   Boyan, B D ^a,b,d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d Emory University   (United States)

Author keywords

Activation; Chondrocyte; Extracellular matrix; Latent TGF 1; Lysophospholipid; Matrix vesicle; TGF 1

Indexed keywords

CHOLINE; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLETHANOLAMINE; LYSOPHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PLASMALOGEN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARTILAGE CELL; CELL GROWTH; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GROWTH PLATE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; CHONDROCYTES; EXTRACELLULAR MATRIX; HUMANS; LYSOPHOSPHATIDYLCHOLINES; LYSOPHOSPHOLIPIDS; MALE; MATRIX METALLOPROTEINASE 3; PHOSPHOLIPASES A; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN D;

EID: 4344617185     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2004.04.006     Document Type: Article

References (54)

1. Pedrozo H.A., Schwartz Z., Gomez R., Ornoy A., Xin-Sheng W., Dallas S.L., Bonewald L.F., Dean D.D., Boyan B.D. Growth plate chondrocytes store latent TGF-β1 in their matrix through latent TGFβ binding protein-1. J. Cell. Physiol. 177:1998;343-354
2. 3 metabolites regulate LTBP1 and latent TGF-β1 expression and latent TGF-β1 incorporation in the extracellular matrix of chondrocytes. J. Cell. Biochem. 72:1999;151-165
3. 3. J. Biol. Chem. 269:1994;28374-28381
4. Dallas S.L., Park-Snyder S., Miyazono K., Twardzik D., Mundy G.R., Bonewald L.F. Characterization and autoregulation of latent transforming growth factor β (TGFβ) complexes in osteoblast-like cell lines. J. Biol. Chem. 269:1994;6815-6822
5. 3 on differentiation of a human osteosarcoma (MG-63). J. Biol. Chem. 267:1992;8943-8949
6. 3 on resting zone chondrocytes is metabolite-specific and mediated by protein kinase C. Connect. Tissue Res. 35:1996;101-106
7. Schwartz Z., Bonewald L.F., Caulfield K., Brooks B.P., Boyan B.D. Direct effects of transforming growth factor-β on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner. Endocrinology. 132:1993;1544-1552
8. 3 1α- and 24-hydroxylase activity in cultured growth plate chondrocytes in a maturation-dependent manner. Calcif. Tissue Int. 64:1999;50-56
9. 3. Bone. 23:1998;465-470
10. Carrington J.L., Reddi A.H. Temporal changes in the response of chick limb bud mesodermal cells to transforming growth factor beta-type 1. Exp. Cell Res. 186:1990;368-373
11. Ballock R.T., Heydemann A., Wakefield L.M., Flanders K.C., Roberts A.B., Sporn M.B. TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases. Dev. Biol. 158:1993;414-429
12. Pedrozo H.A., Schwartz Z., Robinson M., Gomez R., Dean D.D., Bonewald L.F., Boyan B.D. Potential mechanisms for the plasmin mediated release and activation of latent TGF-β1 from the extracellular matrix of growth plate chondrocytes. Endocrinology. 140:1999;5806-5816
13. Nunes I., Gleizes P.-E., Metz C.N., Rifkin D.B. Latent transforming growth factor-b binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β J. Cell Biol. 136:1997;1151-1163
14. Dallas S.L., Miyazono K., Skerry T.M., Mundy G.R., Bonewald L.F. Dual role for the latent transforming growth factor-β binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein. J. Cell Biol. 131:1995;539-549
15. Maeda S., Dean D.D., Schwartz Z., Boyan B.D. Activation of latent transforming growth factor-β1 by stromelysin-1 in extracts of growth plate chondrocyte-derived matrix vesicles. J. Bone Miner. Res. 16:2001;1281-1290
16. Karsdal M.A., Larsen L., Engsig M.T., Lou H., Ferreras M., Lochter A., Delaisse J.M., Foged N.T. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J. Biol. Chem. 277:2002;44061-44067
17. 3 on metalloproteinase activity and cell maturation in growth plate cartilage in vivo. Endocrinology. 14:2001;311-323
18. 3 metabolites. J. Bone Miner. Res. 9:1994;S379
19. 2. Steroids. 64:1999;129-136
20. 3. J. Bone Miner. Res. 14:1999;856-867
21. 2 specific activities. Endocrinology. 123:1988;2878-2884
22. 2 activity via a guanine nucleotide-binding protein in chick myoblasts. Biochim. Biophys. Acta. 1257:1995;274-278
23. Boyan B.D., Ritter N.M. Proteolipid-lipid relationships in normal and vitamin D-deficient chick cartilage. Calcif. Tissue Int. 36:1984;332-337
24. Dziak R., Yang B.M., Leung B.W., Li S., Marzec N., Margarone J., Bobek L. Effects of sphingosine-1-phosphate and lysophosphatidic acid on human osteoblastic cells. Prostaglandins Leukot. Essent. Fat. Acids. 68:2003;239-249
25. 3 induced destabilization. J. Bone Miner. Res. 1:1986;305-311
26. Boskey A.L., Wientroub S. The effect of vitamin D deficiency on rat bone lipid composition. Bone. 7:1986;277-281
27. 2 dependent production of lysophosphlipid. Steroids. 68:2003;423-437
28. Ginsburg I., Misgav R., Pinson A., Varani J., Ward P.A., Kohen R. Synergism among oxidants, proteinases, phospholipases, microbial hemolysins, cationic proteins, and cytokines. Inflammation. 16:1992;519-538
29. 3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors. Endocrinology. 130:1992;2495-2504
30. Boyan B.D., Schwartz Z., Swain L.D., Carnes D.L. Jr., Zislis T. Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro. Bone. 9:1988;185-194
31. Rikitake Y., Hirata K., Yamashita T., Iwai K., Kobayashi S., Itoh H., Ozaki M., Ejiri J., Shiomi M., Inoue N., Kawashima S., Yokoyama M. Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 22:2002;2049-2053
32. 3 induces arachidonate mobilization in embryonic chick myoblasts. Biochim. Biophys. Acta. 1179:1993;98-104
33. Schwartz Z., Schlader D.L., Ramirez V., Kennedy M.B., Boyan B.D. Effects of vitamin D metabolites on collagen production and cell proliferation of growth zone and resting zone cartilage cells in vitro. J. Bone Miner. Res. 4:1989;199-207
34. Neptune E.R., Frischmeyer P.A., Arking D.E., Myers L., Bunton T.E., Gayraud B., Ramirez F., Sakai L.Y., Dietz H.C. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33:2003;407-411
35. Brown P.D., Wakefield L.M., Levinson A.D., Sporn M. Physiochemical activation of recombinant latent transforming growth factor-betas 1, 2 and 3. Growth Factors. 3:1990;35-43
36. Lawrence D.A., Pircher R., Jullien P. Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. Biochem. Biophys. Res. Commun. 133:1985;1026-1034
37. Wong J.T., Tran K., Pierce G.N., Chan A.C., O K., Choy P.C. Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells. J. Biol. Chem. 273:1998;6830-6836
38. Wu L.N., Yoshimori T., Genge B.R., Sauer G.R., Kirsch T., Ishikawa Y., Wuthier R.E. Characterization of the nucleational core complex responsible for mineral induction by growth plate cartilage matrix vesicles. J. Biol. Chem. 268:1993;25084-25094
39. 3 and mediated through protein kinase C (abst.). Trans. Orthop. Res. Soc. 25:2000;996
40. 2 activity of growth zone and resting zone cartilage cells in vitro. Endocrinology. 122:1988;2191-2198
41. Fukushima N., Ishii I., Habara Y., Allen C.B., Chun J. Dual regulation of actin rearrangement through lysophosphatidic acid receptor in neuroblast cell lines: actin depolymerization by Ca(2+)-alpha-actinin and polymerization by rho. Mol. Biol. Cell. 13:2002;2692-2705
42. Lum H., Qiao J., Walter R.J., Huang F., Subbaiah P.V., Kim K.S., Holian O. Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells. Am. J. Physiol, Heart Circ. Physiol. 285:2003;1786-1789
43. Jin Y., Knudsen E., Wang L., Maghazachi A.A. Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization. Eur. J. Immunol. 33:2003;2083-2089
44. Toman R.E., Spiegel S. Lysophospholipid receptors in the nervous system. Neurochem. Res. 27:2002;619-627
45. Korchynskyi O., Dechering K.J., Sijbers A.M., Olijve W., ten Dijke P. Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation. J. Bone Miner. Res. 18:2003;1177-1185
46. Fang X., Gaudette D., Furui T., Mao M., Estrella V., Eder A., Pustilnik T., Sasagawa T., LaPushin R., Yu S., Jaffe R.B., Wiener J.R., Erickson J.R., Mills G.B. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann. N.Y. Acad. Sci. 905:2000;188-208
47. Lin P., Ye R.D. The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis. J. Biol. Chem. 278:2003;14379-14386
48. Fang X., Yu S., LaPushin R., Lu Y., Furui T., Penn L.Z., Stokoe D., Erickson J.R., Bast R.C. Jr., Mills G.B. Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase. Biochem. J. 352(Pt 1):2000;135-143
49. Rong J.X., Berman J.W., Taubman M.B., Fisher E.A. Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 22:2002;1617-1623
50. Silliman C.C., Elzi D.J., Ambruso D.R., Musters R.J., Hamiel C., Harbeck R.J., Paterson A.J., Bjornsen A.J., Wyman T.H., Kelher M., England K.M., McLaughlin-Malaxecheberria N., Barnett C.C., Aiboshi J., Bannerjee A. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J. Leukoc. Biol. 73:2003;511-524
51. Chun J., Weiner J.A., Fukushima N., Contos J.J., Zhang G., Kimura Y., Dubin A., Ishii I., Hecht J.H., Akita C., Kaushal D. Neurobiology of receptor-mediated lysophospholipid signaling. From the first lysophospholipid receptor to roles in nervous system function and development. Ann. N.Y. Acad. Sci. 905:2000;110-117
52. Boyan B.D., Schwartz Z., Carnes D.L. Jr., Ramirez V. The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro. Endocrinology. 122:1988;2851-2860
53. Wu L.N., Genge B.R., Kang M.W., Arsenault A.L., Wuthier R.E. Changes in phospholipid extractability and composition accompany mineralization of chicken growth plate cartilage matrix vesicles. J. Biol. Chem. 277:2002;5126-5133
54. Wuthier R.E. Lipids of mineralizing epephyseal tissues in the bovine fetus. J. Lipid Res. 9:1968;68-78